Medical Care Technologies Inc. (OTC PINK:MDCE) Announces CEO Insider Purchase of 50 Million Shares of MDCE Common Stock

Rhea-AI Summary

Medical Care Technologies (OTC PINK:MDCE) announced that CEO Marshall Perkins purchased 50,000,000 shares of MDCE common stock on the open market at an average price of $0.0003 per share on November 19, 2025.

The purchase was made with personal funds, did not involve issuance of new company shares, and therefore did not constitute a corporate action. The company reported an unchanged outstanding share count of 3,316,305,988 common shares as of the release date.

Management said the purchase reflects alignment with shareholders and ongoing focus on transparent communications while the company pursues activities in health technology and digital wellness.

Positive

• CEO purchase of 50,000,000 shares on 11/19/2025
• No new shares issued; transaction did not dilute outstanding shares

Negative

• None.

News Market Reaction

+33.33%

1 alert

+33.33% News Effect

On the day this news was published, MDCE gained 33.33%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

CEO's personal open-market investment reflects long-term alignment with shareholders and continued commitment to transparency, excellence and innovation.

MESA, ARIZONA / ACCESS Newswire / November 20, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) (the "Company") today announced that its Chief Executive Officer, Marshall Perkins, purchased 50,000,000 shares of MDCE common stock on the open market at an average purchase price of $0.0003 per share on November 19, 2025.

The shares were purchased using personal funds and reflect a personal investment by Mr. Perkins. No new shares were issued by the Company in connection with this transaction, and therefore it does not constitute a corporate action.

As of the date of this release, the Company's outstanding share count remains 3,316,305,988 shares of common stock.

"This purchase represents my personal investment decision and continued confidence in the Company's business direction," said Marshall Perkins, Chief Executive Officer of Medical Care Technologies Inc. "We remain focused on maintaining transparent communication and operational progress for our shareholders."

The Company continues to pursue its business activities in the health technology and digital wellness sector and will provide updates through OTC Markets disclosures as developments warrant.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC Pink: MDCE) is a development-stage health technology company focused on integrating artificial intelligence into consumer-facing health and wellness applications. The Company operates under the Alternative Reporting Standard and provides regular updates through its OTC Markets profile at www.otcmarkets.com/stock/MDCE.

For more information, please visit www.medicalcaretechnologies.com.

Contact Information

Medical Care Technologies Inc.
1910 S. Stapley Drive, Suite 221
Mesa, AZ 85204
Phone: +1 (480) 645-0750
Email: info@infiniteauctions.com
Website: www.mdcestock.com

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause such differences include general economic conditions, changes in market demand, competitive factors, and regulatory developments. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law.

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What did MDCE announce about insider purchases on November 20, 2025?

MDCE announced CEO Marshall Perkins purchased 50,000,000 shares on 11/19/2025 at an average price of $0.0003 per share.

Did the MDCE insider purchase involve new shares or company issuance?

No; the company said no new shares were issued and the purchase was made with personal funds.

How many MDCE shares were outstanding after the CEO purchase?

The company reported 3,316,305,988 shares of common stock outstanding as of the release date.

When did Marshall Perkins purchase MDCE shares and at what price?

He purchased shares on November 19, 2025 at an average price of $0.0003 per share.

What does the MDCE release say about the purpose of the CEO purchase?

The company said the purchase reflects the CEO’s personal investment decision and confidence in the company’s direction.

Where will MDCE provide future updates about business developments?

MDCE said it will provide updates through OTC Markets disclosures as developments warrant.